Cargando…
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study
BACKGROUND: The role of adjuvant chemoradiation therapy for ampullary carcinoma is unknown. Previous literature suggests that certain populations with high risk factors for recurrence may benefit from adjuvant chemoradiation. We combined the experience of two institutions to better delineate which p...
Autores principales: | Narang, Amol K, Miller, Robert C, Hsu, Charles C, Bhatia, Sumita, Pawlik, Timothy M, Laheru, Dan, Hruban, Ralph H, Zhou, Jessica, Winter, Jordan M, Haddock, Michael G, Donohue, John H, Schulick, Richard D, Wolfgang, Christopher L, Cameron, John L, Herman, Joseph M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204241/ https://www.ncbi.nlm.nih.gov/pubmed/21951377 http://dx.doi.org/10.1186/1748-717X-6-126 |
Ejemplares similares
-
Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
por: Hsu, Charles C., et al.
Publicado: (2010) -
The “Race” Toward Diversity, Inclusion, and Equity in Pathology: The Johns Hopkins Experience
por: Ware, Alisha D., et al.
Publicado: (2019) -
Johns Hopkins Hospital
Publicado: (1914) -
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017) -
The Johns Hopkins Hospital Reports
por: Struthers, J. W.
Publicado: (1904)